+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Tendonitis Treatment Market Size, Share & Industry Trends Analysis Report By Type (Therapy and Surgery), By Therapy Type (Physical Therapy, Hot & Cold Therapy and Shockwave Therapy), By Condition, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 81 Pages
  • November 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709580
The North America Tendonitis Treatment Market should witness market growth of 3.1% CAGR during the forecast period (2022-2028).

Tendinitis affected area's swelling can be reduced by using an ice pack. Pain and inflammation can be diminished by applying ice for 10 to 15 minutes once or twice daily. Ice should always be covered with a towel to prevent coming into contact with the skin. Alternating between heat and ice is also helpful to some people.

They can take a heated bath, apply hot compresses, or use hot towels. For wounds sustained within the last 48 hours, ice is typically the best treatment. Heat might perhaps be a better choice. The lower part of the tendon, where it connects to the heel bone, is affected by insertional Achilles tendinitis. Damaged tendon fibers may calcify (harden) over time in both insertional and non-insertional Achilles tendonitis.

In cases of insertional Achilles tendonitis, bone spurs frequently develop on the heel. Although it can happen at any time or level of activity, insertional Achilles tendinitis still most frequently affects runners. It typically results from calf muscular tension, which puts more strain on the area where the Achilles tendon inserts.

The National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention (CDC) projects that in the United States year 2020, there were around 22,887,137 visits for non-fatal injuries to emergency rooms. Another factor driving up demand for tendonitis treatment in the region is the region's aging population. According to the world population aging estimate, there will be over 80 million individuals over 65 in Canada and the United States by 2030, up from about 60 million in 2019.

The US market dominated the North America Tendonitis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $74,269.9 million by 2028. The Canada market is poised to grow at a CAGR of 5.4% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 4.5% during (2022-2028).

Based on Type, the market is segmented into Therapy and Surgery. Based on Therapy Type, the market is segmented into Physical Therapy, Hot & Cold Therapy and Shockwave Therapy. Based on Condition, the market is segmented into Achilles Tendonitis, Jumper’s Knee, Tennis Elbow, Pitcher’s Elbow, Swimmer’s Shoulder and Golfer’s Elbow. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.

Scope of the Study

By Type

  • Therapy
    • Physical Therapy
    • Hot & Cold Therapy
    • Shockwave Therapy
  • Surgery

By Condition

  • Achilles Tendonitis
  • Jumper’s Knee
  • Tennis Elbow
  • Pitcher’s Elbow
  • Swimmer’s Shoulder
  • Golfer’s Elbow

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Merck & Co., Inc.
  • Bayer AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Almatica Pharma, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tendonitis Treatment Market, by Type
1.4.2 North America Tendonitis Treatment Market, by Condition
1.4.3 North America Tendonitis Treatment Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies Deployed in Tendonitis Treatment Market
Chapter 4. North America Tendonitis Treatment Market by Type
4.1 North America Therapy Market by Country
4.2 North America Tendonitis Treatment Market by Therapy Type
4.2.1 North America Physical Therapy Market by Country
4.2.2 North America Hot & Cold Therapy Market by Country
4.2.3 North America Shockwave Therapy Market by Country
4.3 North America Surgery Market by Country
Chapter 5. North America Tendonitis Treatment Market by Condition
5.1 North America Achilles Tendonitis Market by Country
5.2 North America Jumper’s Knee Market by Country
5.3 North America Tennis Elbow Market by Country
5.4 North America Pitcher’s Elbow Market by Country
5.5 North America Swimmer’s Shoulder Market by Country
5.6 North America Golfer’s Elbow Market by Country
Chapter 6. North America Tendonitis Treatment Market by Country
6.1 US Tendonitis Treatment Market
6.1.1 US Tendonitis Treatment Market by Type
6.1.1.1 US Tendonitis Treatment Market by Therapy Type
6.1.2 US Tendonitis Treatment Market by Condition
6.2 Canada Tendonitis Treatment Market
6.2.1 Canada Tendonitis Treatment Market by Type
6.2.1.1 Canada Tendonitis Treatment Market by Therapy Type
6.2.2 Canada Tendonitis Treatment Market by Condition
6.3 Mexico Tendonitis Treatment Market
6.3.1 Mexico Tendonitis Treatment Market by Type
6.3.1.1 Mexico Tendonitis Treatment Market by Therapy Type
6.3.2 Mexico Tendonitis Treatment Market by Condition
6.4 Rest of North America Tendonitis Treatment Market
6.4.1 Rest of North America Tendonitis Treatment Market by Type
6.4.1.1 Rest of North America Tendonitis Treatment Market by Therapy Type
6.4.2 Rest of North America Tendonitis Treatment Market by Condition
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent Strategies and Developments
7.1.5.1 Approvals and Trials
7.1.6 SWOT Analysis
7.2 AstraZeneca PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Acquisition and Mergers
7.3 GlaxoSmithKline PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent Strategies and Developments
7.3.5.1 Acquisitions and Mergers
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent Strategies and Developments
7.4.5.1 Acquisition and Mergers
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent Strategies and Developments
7.5.5.1 Partnerships, Collaborations, and Agreements
7.6 Boehringer Ingelheim International Gmbh
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional & Segmental Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent Strategies and Developments
7.6.5.1 Product Launches and Product Expansions
7.6.5.2 Acquisition and Mergers
7.7 Bayer AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent Strategies and Developments
7.8.5.1 Acquisition and Mergers
7.9 Almatica Pharma LLC (Alvogen, Inc.)
7.9.1 Company Overview

Companies Mentioned

  • Merck & Co., Inc.
  • Bayer AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Almatica Pharma, Inc.

Methodology

Loading
LOADING...